Mar 12, 2024 | News and Updates
On March 12, 2024, a three judge panel of the 8th Circuit federal court of appeals confirmed that Arkansas’s law protecting 340B contract pharmacies in the state against discriminatory practices by manufacturers is not preempted by federal law. (AstraZeneca...
Mar 4, 2024 | News and Updates
Eyman Partners is pleased to announce that attorney Sandra George has joined the firm as a Senior Advisor. Sandra joins us after nearly two decades of federal health care oversight experience. This follows several years of private practice alongside Barbara Eyman,...
Feb 24, 2024 | News and Updates
On February 23, 2024, CMS released a final rule implementing the new policy on counting third-party payer costs and revenues in the hospital-specific disproportionate share hospital (DSH) cap, as mandated by Congress in the Consolidated Appropriations Act of 2021. The...
Jan 16, 2024 | News and Updates
In January, CMS approved an amendment to New York’s section 1115 demonstration that will provide significant investments in advancing health equity and supporting the delivery of health-related social need (HRSN) services. A central component of the approved...
Nov 3, 2023 | News and Updates
A federal court in South Carolina issued the first federal court decision related to the definition of a patient to whom a covered entity may provide 340B-discounted drugs. In Genesis Health Care, Inc. v. Becerra, the court concluded that HRSA’s enforcement action...
Jul 25, 2023 | News and Updates
CMS has proposed a long-awaited remedy to make 340B hospitals whole for nearly five years of cuts under the Medicare outpatient prospective payment system (OPPS) that the Supreme Court deemed unlawful in 2022. In welcome news, CMS has proposed to repay impacted...
